Overview and Scope
Veterinary antimicrobial susceptibility testing refers to a critical tool for the veterinarian in choosing the best drug to treat bacterial infections in animals. Veterinary antimicrobial susceptibility testing is used to provide a treatment history, including any previously used specific antibiotics as well as any clinical background that might have an impact on the patient’s typical bacterial flora.
Sizing and Forecast
The veterinary antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $34.78 billion in 2023 to $37.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to environmental concerns, precision medicine demand, one health approach, consumer awareness, companion animal healthcare growth.
The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $50.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to antibiotic resistance mitigation, regulatory requirements, global health events impact, rising pet ownership.. Major trends in the forecast period include innovative solutions, regulatory emphasis, zoonotic disease control, livestock industry standards.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report
Segmentation & Regional Insights
The veterinary antimicrobial susceptibility testing market covered in this report is segmented –
1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2023. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp
Major Driver Impacting Market Growth
The rising prevalence of zoonotic diseases is expected to propel the growth of the veterinary antimicrobial susceptibility testing market going forward. Zoonotic disease refers to a contagious illness that can spread from one species of animal to another, including from humans to animals (or from humans to humans). The rising prevalence of zoonotic diseases will create a need to test and determine the best animal medication. Veterinary antimicrobial susceptibility testing aids in choosing the best drug to treat bacterial infections in animals by checking treatment history and others. For instance, In July 2022, according to an article published by the world health organization, a US-based government agency, stated that there was a 64% rise in the number of zoonotic cases in Africa. Furthermore, zoonotic illnesses are on the increase both internationally and in India. These emerging infectious diseases in humans account for 60% of cases, with 816 zoonotic pathogens out of 1407 human pathogens. Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary antimicrobial susceptibility testing market.
Key Industry Players
Major companies operating in the veterinary antimicrobial susceptibility testing market report are BioMérieux SA, Becton, Dickinson and Company, Bioguard Corporation, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Cepheid Inc., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, GenMark Diagnostics Inc., IDEXX Laboratories Inc., Luminex Corporation, Merck Co. & KGaA, Microbiologics Inc., Nanosphere Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
The veterinary antimicrobial susceptibility testing market report table of contents includes:
1. Executive Summary
2. Veterinary Antimicrobial Susceptibility Testing Market Characteristics
3. Veterinary Antimicrobial Susceptibility Testing Market Trends And Strategies
4. Veterinary Antimicrobial Susceptibility Testing Market – Macro Economic Scenario
5. Global Veterinary Antimicrobial Susceptibility Testing Market Size and Growth
….
31. Veterinary Antimicrobial Susceptibility Testing Market Other Major And Innovative Companies
32. Global Veterinary Antimicrobial Susceptibility Testing Market Competitive Benchmarking
33. Global Veterinary Antimicrobial Susceptibility Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Veterinary Antimicrobial Susceptibility Testing Market
35. Veterinary Antimicrobial Susceptibility Testing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
